{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T11:43:07Z","timestamp":1771674187123,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T00:00:00Z","timestamp":1540771200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13054-018-2207-6","type":"journal-article","created":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T14:56:31Z","timestamp":1540565791000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Carbonic anhydrase inhibitors in patients with respiratory failure and metabolic alkalosis: a systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1186","volume":"22","author":[{"given":"Bassem Y","family":"Tanios","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam O","family":"Omran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Noujeim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Lotfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samir S","family":"Mallat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre K","family":"Bou-Khalil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elie A","family":"Akl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Houssam S","family":"Itani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,29]]},"reference":[{"issue":"2","key":"2207_CR1","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1378\/chest.124.2.490","volume":"124","author":"AE Holland","year":"2003","unstructured":"Holland AE, Wilson JW, Kotsimbos TC, Naughton MT. Metabolic alkalosis contributes to acute hypercapnic respiratory failure in adult cystic fibrosis. Chest. 2003;124(2):490\u20133.","journal-title":"Chest"},{"issue":"12","key":"2207_CR2","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1097\/00003246-198012000-00005","volume":"8","author":"JE Hodgkin","year":"1980","unstructured":"Hodgkin JE, Soeprono FF, Chan DM. Incidence of metabolic alkalemia in hospitalized patients. Crit Care Med. 1980;8(12):725\u20138.","journal-title":"Crit Care Med"},{"issue":"4","key":"2207_CR3","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/cc11323","volume":"16","author":"N Heming","year":"2012","unstructured":"Heming N, Urien S, Faisy C. Acetazolamide: a second wind for a respiratory stimulant in the intensive care unit? Critical care (London, England). 2012;16(4):318.","journal-title":"Critical care (London, England)"},{"issue":"6","key":"2207_CR4","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3109\/15412550903341448","volume":"6","author":"A Banga","year":"2009","unstructured":"Banga A, Khilnani GC. Post-hypercapnic alkalosis is associated with ventilator dependence and increased ICU stay. Copd. 2009;6(6):437\u201340.","journal-title":"Copd"},{"key":"2207_CR5","doi-asserted-by":"crossref","unstructured":"Jones PW, Greenstone M. Carbonic anhydrase inhibitors for hypercapnic ventilatory failure in chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2001(1):Cd002881. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11279770 .","DOI":"10.1002\/14651858.CD002881"},{"issue":"5","key":"2207_CR6","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1001\/jama.2016.0019","volume":"315","author":"C Faisy","year":"2016","unstructured":"Faisy C, Meziani F, Planquette B, Clavel M, Gacouin A, Bornstain C, et al. Effect of acetazolamide vs placebo on duration of invasive mechanical ventilation among patients with chronic obstructive pulmonary disease: a randomized clinical trial. JAMA. 2016;315(5):480\u20138.","journal-title":"JAMA"},{"issue":"1","key":"2207_CR7","first-page":"37","volume":"20","author":"V Fontana","year":"2016","unstructured":"Fontana V, Santinelli S, Internullo M, Marinelli P, Sardo L, Alessandrini G, et al. Effect of acetazolamide on post-NIV metabolic alkalosis in acute exacerbated COPD patients. Eur Rev Med Pharmacol Sci. 2016;20(1):37\u201343.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2207_CR8","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.pupt.2017.03.002","volume":"44","author":"G Rialp Cervera","year":"2017","unstructured":"Rialp Cervera G, Raurich Puigdevall JM, Moran Chorro I, Martin Delgado MC, Heras la Calle G, Mas Serra A, et al. Effects of early administration of acetazolamide on the duration of mechanical ventilation in patients with chronic obstructive pulmonary disease or obesity-hypoventilation syndrome with metabolic alkalosis. A randomized trial. Pulm Pharmacol Ther. 2017;44:30\u20137.","journal-title":"Pulm Pharmacol Ther"},{"issue":"7","key":"2207_CR9","doi-asserted-by":"publisher","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","volume":"6","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100.","journal-title":"PLoS Med"},{"key":"2207_CR10","unstructured":"Higgins JPT GS. Cochrane handbook for systematic reviews of interventions Version 5.1.0 The Cochrane Collaboration, 2011; 2011 [updated updated March 2011]. Available from: Available from https:\/\/handbook-5-1.cochrane.org\/ . Accessed Aug 2017."},{"key":"2207_CR11","first-page":"343","volume":"d5928","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ (Clinical research ed). 2011;d5928:343.","journal-title":"BMJ (Clinical research ed)"},{"issue":"5437","key":"2207_CR12","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1136\/bmj.1.5437.759","volume":"1","author":"WM Nelson","year":"1965","unstructured":"Nelson WM, Wallace WF. Oral respiratory stimulants in chronic respiratory failure: double-blind controlled trial of amiphenazole and dichlorphenamide. Br Med J. 1965;1(5437):759\u201362.","journal-title":"Br Med J"},{"issue":"1","key":"2207_CR13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jclinepi.2005.06.006","volume":"59","author":"TA Furukawa","year":"2006","unstructured":"Furukawa TA, Barbui C, Cipriani A, Brambilla P, Watanabe N. Imputing missing standard deviations in meta-analyses can provide accurate results. J Clin Epidemiol. 2006;59(1):7\u201310.","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"2207_CR14","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s00134-010-1795-7","volume":"36","author":"C Faisy","year":"2010","unstructured":"Faisy C, Mokline A, Sanchez O, Tadie JM, Fagon JY. Effectiveness of acetazolamide for reversal of metabolic alkalosis in weaning COPD patients from mechanical ventilation. Intensive Care Med. 2010;36(5):859\u201363.","journal-title":"Intensive Care Med"},{"key":"2207_CR15","unstructured":"Hacki M, Waldeck G, Brandli O. Acetazolamide in hypercapnic chronic obstructive pulmonary disease: a renaissance? Schweizerische medizinische Wochenschrift [Internet]. 1983; 113(3):[110\u20134 pp.]. Available from: https:\/\/www.cochranelibrary.com\/central\/doi\/10.1002\/central\/CN-00175914\/full ."},{"key":"2207_CR16","unstructured":"Rohatgi A. WebPlotDigitizer January, 2018. Version 4.1:[Available from: https:\/\/automeris.io\/WebPlotDigitizer . Accessed Feb 2018."},{"issue":"7644","key":"2207_CR17","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","volume":"336","author":"L Wood","year":"2008","unstructured":"Wood L, Egger M, Gluud LL, Schulz KF, Juni P, Altman DG, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ (Clinical research ed). 2008;336(7644):601\u20135.","journal-title":"BMJ (Clinical research ed)."},{"issue":"2","key":"2207_CR18","doi-asserted-by":"publisher","first-page":"e57132","DOI":"10.1371\/journal.pone.0057132","volume":"8","author":"EA Akl","year":"2013","unstructured":"Akl EA, Johnston BC, Alonso-Coello P, Neumann I, Ebrahim S, Briel M, et al. Addressing dichotomous data for participants excluded from trial analysis: a guide for systematic reviewers. PLoS One. 2013;8(2):e57132.","journal-title":"PLoS One"},{"issue":"9","key":"2207_CR19","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.jclinepi.2013.03.014","volume":"66","author":"S Ebrahim","year":"2013","unstructured":"Ebrahim S, Akl EA, Mustafa RA, Sun X, Walter SD, Heels-Ansdell D, et al. Addressing continuous data for participants excluded from trial analysis: a guide for systematic reviewers. J Clin Epidemiol. 2013;66(9):1014\u201321 e1.","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"2207_CR20","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.jclinepi.2013.11.014","volume":"67","author":"S Ebrahim","year":"2014","unstructured":"Ebrahim S, Johnston BC, Akl EA, Mustafa RA, Sun X, Walter SD, et al. Addressing continuous data measured with different instruments for participants excluded from trial analysis: a guide for systematic reviewers. J Clin Epidemiol. 2014;67(5):560\u201370.","journal-title":"J Clin Epidemiol"},{"key":"2207_CR21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jclinepi.2017.05.005","volume":"87","author":"GH Guyatt","year":"2017","unstructured":"Guyatt GH, Ebrahim S, Alonso-Coello P, Johnston BC, Mathioudakis AG, Briel M, et al. GRADE guidelines 17: assessing the risk of bias associated with missing participant outcome data in a body of evidence. J Clin Epidemiol. 2017;87:14\u201322.","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"2207_CR22","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","volume":"64","author":"G Guyatt","year":"2011","unstructured":"Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction\u2014GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383\u201394.","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"2207_CR23","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","volume":"64","author":"GH Guyatt","year":"2011","unstructured":"Guyatt GH, Oxman AD, Vist G, Kunz R, Brozek J, Alonso-Coello P, et al. GRADE guidelines: 4. Rating the quality of evidence\u2014study limitations (risk of bias). J Clin Epidemiol. 2011;64(4):407\u201315.","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"2207_CR24","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.jclinepi.2011.03.017","volume":"64","author":"GH Guyatt","year":"2011","unstructured":"Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. GRADE guidelines: 7. Rating the quality of evidence\u2014inconsistency. J Clin Epidemiol. 2011;64(12):1294\u2013302.","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"2207_CR25","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/j.jclinepi.2011.04.014","volume":"64","author":"GH Guyatt","year":"2011","unstructured":"Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. GRADE guidelines: 8. Rating the quality of evidence\u2014indirectness. J Clin Epidemiol. 2011;64(12):1303\u201310.","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"2207_CR26","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.jclinepi.2011.01.011","volume":"64","author":"GH Guyatt","year":"2011","unstructured":"Guyatt GH, Oxman AD, Montori V, Vist G, Kunz R, Brozek J, et al. GRADE guidelines: 5. Rating the quality of evidence\u2014publication bias. J Clin Epidemiol. 2011;64(12):1277\u201382.","journal-title":"J Clin Epidemiol"},{"key":"2207_CR27","unstructured":"GRADEpro GDT: GRADEpro Guideline Development Tool [Software]. McMaster University, 2015 (developed by Evidence Prime, Inc.). Available from gradepro.org . Accessed Apr 2018."},{"issue":"4","key":"2207_CR28","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/crj.12025","volume":"7","author":"R Gulsvik","year":"2013","unstructured":"Gulsvik R, Skjorten I, Undhjem K, Holo L, Frostad A, Saure EW, et al. Acetazolamide improves oxygenation in patients with respiratory failure and metabolic alkalosis. Clin Respir J. 2013;7(4):390\u20136.","journal-title":"Clin Respir J"},{"issue":"5","key":"2207_CR29","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1183\/09031936.94.07050850","volume":"7","author":"PJ Vos","year":"1994","unstructured":"Vos PJ, Folgering HT, de Boo TM, Lemmens WJ, van Herwaarden CL. Effects of chlormadinone acetate, acetazolamide and oxygen on awake and asleep gas exchange in patients with chronic obstructive pulmonary disease (COPD). Eur Respir J. 1994;7(5):850\u20135.","journal-title":"Eur Respir J"},{"issue":"3","key":"2207_CR30","first-page":"110","volume":"113","author":"MA Hacki","year":"1983","unstructured":"Hacki MA, Waldeck G, Brandli O. Acetazolamide in hypercapnic chronic obstructive lung disease\u2014a renaissance? Schweizerische Medizinische Wochenschrift. 1983;113(3):110\u20134.","journal-title":"Schweizerische Medizinische Wochenschrift"},{"issue":"4","key":"2207_CR31","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1164\/arrd.1983.127.4.405","volume":"127","author":"JB Skatrud","year":"1983","unstructured":"Skatrud JB, Dempsey JA. Relative effectiveness of acetazolamide versus medroxyprogesterone acetate in correction of chronic carbon dioxide retention. Am Rev Respir Dis. 1983;127(4):405\u201312.","journal-title":"Am Rev Respir Dis"},{"issue":"5","key":"2207_CR32","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1378\/chest.123.5.1450","volume":"123","author":"M Wagenaar","year":"2003","unstructured":"Wagenaar M, Vos P, Heijdra Y, Teppema L, Folgering H, Correspondence A, et al. Comparison of acetazolamide and medroxyprogesterone as respiratory stimulants in hypercapnic patients with COPD. Chest. 2003;123(5):1450\u20139.","journal-title":"Chest"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-018-2207-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13054-018-2207-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-018-2207-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T12:11:14Z","timestamp":1694002274000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-018-2207-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,29]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2207"],"URL":"https:\/\/doi.org\/10.1186\/s13054-018-2207-6","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,29]]},"assertion":[{"value":"20 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have agreed to the publication of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"275"}}